Home
About
Overview
Sharing Data
ORCID
Help
History (16)
Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours.
Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
Patient Perceptions Impact Progression to Third-Line Therapy for Treatment of Overactive Bladder.
Principal Investigator
Multi-Center Validation of the McGovern Pediatric Blunt Cerebrovascular Injury Screening Score.
See All 16 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Multi-Center Validation of the McGovern Pediatric Blunt Cerebrovascular Injury Screening Score.
Multi-Center Validation of the McGovern Pediatric Blunt Cerebrovascular Injury Screening Score. J Neurotrauma. 2023 07; 40(13-14):1451-1458.
View in:
PubMed
subject areas
Cerebrovascular Trauma
Child
Cohort Studies
Humans
Multiple Trauma
Retrospective Studies
Tomography, X-Ray Computed
Wounds, Nonpenetrating
authors with profiles
Irma Ugalde